Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.53)
# 1,011
Out of 4,587 analysts
107
Total ratings
52.7%
Success rate
20.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $27 → $37 | $26.21 | +41.17% | 12 | Jul 30, 2026 | |
| ANNX Annexon | Maintained: Buy | $14 | $5.11 | +173.97% | 7 | Jul 30, 2026 | |
| PRQR ProQR Therapeutics | Maintained: Buy | $12 | $1.74 | +589.66% | 9 | Jun 29, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $110 | $27.66 | +297.69% | 19 | Jun 22, 2026 | |
| GPCR Structure Therapeutics | Rated: Buy | $100 → $70 | $47.80 | +46.44% | 19 | Jun 11, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $1.74 | +1,052.74% | 11 | May 29, 2026 | |
| SKYE Skye Bioscience | Maintained: Buy | $20 | $0.6025 | +3,219.50% | 7 | May 21, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $50 | $25.15 | +98.81% | 9 | May 21, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $50 | $29.42 | +69.95% | 10 | May 8, 2026 | |
| IVA Inventiva | Maintained: Buy | $24 | $4.59 | +423.45% | 4 | Jan 28, 2026 |
ACADIA Pharmaceuticals
Jul 30, 2026
Maintained: Buy
Price Target: $27 → $37
Current: $26.21
Upside: +41.17%
Annexon
Jul 30, 2026
Maintained: Buy
Price Target: $14
Current: $5.11
Upside: +173.97%
ProQR Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $12
Current: $1.74
Upside: +589.66%
Maze Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $110
Current: $27.66
Upside: +297.69%
Structure Therapeutics
Jun 11, 2026
Rated: Buy
Price Target: $100 → $70
Current: $47.80
Upside: +46.44%
PepGen
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $1.74
Upside: +1,052.74%
Skye Bioscience
May 21, 2026
Maintained: Buy
Price Target: $20
Current: $0.6025
Upside: +3,219.50%
Dyne Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $50
Current: $25.15
Upside: +98.81%
Stoke Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $50
Current: $29.42
Upside: +69.95%
Inventiva
Jan 28, 2026
Maintained: Buy
Price Target: $24
Current: $4.59
Upside: +423.45%